Nalaganje...
Alzheimer's disease drug development pipeline: 2019
INTRODUCTION: Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. METHODS:...
Shranjeno v:
| izdano v: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6617248/ https://ncbi.nlm.nih.gov/pubmed/31334330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.05.008 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|